|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61P 35/00 |
| (11) | Patento numeris | 3044234 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13893636.4 |
| Europos patento paraiškos padavimo data | 2013-09-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2013/083467 |
| Data | 2013-09-13 |
| (87) | Numeris | WO 2015/035606 |
| Data | 2015-03-19 |
| (72) |
SONG, Jing, CN
LI, Kang, CN
ZHANG, Tong, CN
XU, Lanlan, CN
LIU, Qi, CN
PENG, Hao, CN
|
| (73) |
BeiGene Switzerland GmbH,
c/o VISCHER AG Aeschenvorstadt 4, 4051 Basel,
CH
|
| (54) | ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS |
| ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS |